ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.

Insulet, an Acton-based medical device firm specializing in diabetes treatment, has launched commercialization efforts for its tubeless insulin device in the United Kingdom. The tubeless insulin ...

The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a U.S. Food and Drug Administration announcement on Wednesday ...

CHICAGO — Insulin pumps are used by tens of thousands of teenagers worldwide with Type 1 diabetes, but they can be risky and have been linked to injuries and even deaths, a review by federal ...

Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...

AT278 (500U/mL) is the only ultra-concentrated and ultra-rapid acting insulin in development designed to enable the next generation of longer-wear and miniaturised automated insulin delivery (AID) ...

Altitude changes during commercial flights may affect the blood glucose levels of people with type 1 diabetes who are treated with insulin pump therapy, according to new research to be presented at ...

Several types of insulin pumps are being recalled by a medical device company because of a dangerous flaw that could affect more than 322,000 users with Type 1 diabetes. The Food and Drug ...